Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. (Q46013208)

18 December 2017

title

Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. (English)

1 reference

18 December 2017

author name string

Linda T Tran

series ordinal

1

1 reference

18 December 2017

Kathleen M MacLeod

series ordinal

2

1 reference

18 December 2017

John H McNeill

series ordinal

3

1 reference

18 December 2017

publication date

7 May 2009

1 reference

18 December 2017

Molecular and Cellular Biochemistry

published in

1 reference

18 December 2017

volume

330

1 reference

18 December 2017

issue

1-2

1 reference

18 December 2017

page(s)

219-228

1 reference

18 December 2017

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Insulin and hypertension: a causal relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Fructose-induced insulin resistance and hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Female rats are protected against fructose-induced changes in metabolism and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0136-Z

Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats

21 January 2018

1 reference

12 December 2020

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1 reference

12 December 2020

A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

1 reference

12 December 2020

No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome

1 reference

12 December 2020

Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment

1 reference

12 December 2020

Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats

1 reference

12 December 2020

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

12 December 2020

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

12 December 2020

Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.

1 reference

12 December 2020

Decreased vascular reactivity in metformin-treated fructose-hypertensive rats

1 reference

12 December 2020

Age-associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-alpha antagonism

1 reference

12 December 2020

Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging

1 reference

12 December 2020

Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats

1 reference

12 December 2020

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

1 reference

12 December 2020

Insulin Resistance, Hyperinsulinemia, and Coronary Artery Disease: A Complex Metabolic Web

1 reference

12 December 2020

Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.

1 reference

12 December 2020

Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus

1 reference

12 December 2020

A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone

1 reference

12 December 2020

Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat.

1 reference

12 December 2020

Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women

1 reference

12 December 2020

Effect of TNF-alpha--converting enzyme inhibitor on insulin resistance in fructose-fed rats

1 reference

12 December 2020

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

12 December 2020

Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.

1 reference

12 December 2020

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

1 reference

12 December 2020

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists

1 reference

12 December 2020

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

12 December 2020

Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure

1 reference

12 December 2020

Effects of etanercept in patients with the metabolic syndrome

1 reference

12 December 2020

Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome

1 reference

12 December 2020

An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha.

1 reference

12 December 2020

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

1 reference

12 December 2020

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

1 reference

12 December 2020

Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome

1 reference

12 December 2020

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

12 December 2020

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

1 reference

12 December 2020

Tumor necrosis factor and interleukin-1 may regulate renin secretion

1 reference

12 December 2020

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

1 reference

12 December 2020

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

12 December 2020

Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension

1 reference

12 December 2020

Integrating cell-signalling pathways with NF-kappaB and IKK function

1 reference

12 December 2020

Validation in awake rats of a tail-cuff method for measuring systolic pressure

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

The role of TNF-alpha in insulin resistance

1 reference

12 December 2020

Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

1 reference

12 December 2020

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

1 reference

12 December 2020

Signaling to NF-kappaB

1 reference

12 December 2020

Defective endothelium-dependent relaxation in fructose-hypertensive rats

1 reference

12 December 2020

Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

1 reference

12 December 2020

Tumor necrosis factor-alpha and vascular angiotensin II in estrogen-deficient rats.

1 reference

12 December 2020

10.1007/S11010-009-0136-Z

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017